70 related articles for article (PubMed ID: 18434949)
1. Europe extends Viread indication for chronic hepatitis B.
AIDS Patient Care STDS; 2008 Apr; 22(4):350. PubMed ID: 18434949
[No Abstract] [Full Text] [Related]
2. [Chronic hepatitis B. Tenofovir--the right choice from the beginning].
MMW Fortschr Med; 2008 May; 150(21):42-3. PubMed ID: 18575255
[No Abstract] [Full Text] [Related]
3. Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity.
Prescrire Int; 2009 Jun; 18(101):116. PubMed ID: 19637428
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
[No Abstract] [Full Text] [Related]
5. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
Reijnders JG; Janssen HL
J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
[No Abstract] [Full Text] [Related]
6. [Drug approval studies of Viread. As effective in HBeAg positive as also in HBeAg negative patients].
MMW Fortschr Med; 2008 May; 150(21):43. PubMed ID: 18578068
[No Abstract] [Full Text] [Related]
7. FDA grants tentative approval to first generic version of antiretroviral Viread.
AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039
[No Abstract] [Full Text] [Related]
8. [New option for successful therapy of chronic hepatitis B].
Ortleb J
Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1565. PubMed ID: 12899163
[No Abstract] [Full Text] [Related]
9. Tenofovir (viread) receives FDA approval.
AIDS Alert; 2002 Jan; 17(1):10-1. PubMed ID: 11862732
[No Abstract] [Full Text] [Related]
10. Tenofovir salvage for nucleoside experienced patients: muddy waters?
Mutimer D
Gut; 2011 Feb; 60(2):148-50. PubMed ID: 21205876
[No Abstract] [Full Text] [Related]
11. Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.
Liu Y; Wang CM; Cheng J; Liang ZL; Zhong YW; Ren XQ; Xu ZH; Zoulim F; Xu DP
Chin Med J (Engl); 2009 Jul; 122(13):1585-6. PubMed ID: 19719953
[No Abstract] [Full Text] [Related]
12. Chronic hepatitis B: update 2009.
Lok AS; McMahon BJ
Hepatology; 2009 Sep; 50(3):661-2. PubMed ID: 19714720
[No Abstract] [Full Text] [Related]
13. FDA notifications. FDA's tentative approval for generic Tenofovir.
AIDS Alert; 2008 Jan; 23(1):11-2. PubMed ID: 18572475
[No Abstract] [Full Text] [Related]
14. Tenofovir for the treatment of hepatitis B virus.
Jenh AM; Thio CL; Pham PA
Pharmacotherapy; 2009 Oct; 29(10):1212-27. PubMed ID: 19792994
[TBL] [Abstract][Full Text] [Related]
15. Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD.
Hilgendorf I; Loebermann M; Borchert K; Junghanss C; Freund M; Schmitt M
Bone Marrow Transplant; 2011 Sep; 46(9):1274-5. PubMed ID: 21151183
[No Abstract] [Full Text] [Related]
16. Two-year data released on Viread for chronic hepatitis B.
AIDS Patient Care STDS; 2008 Nov; 22(11):921. PubMed ID: 19025487
[No Abstract] [Full Text] [Related]
17. Analogs and fibrosis regression in hepatitis B.
Akarca US
Gastroenterol Clin Biol; 2010; 34(6-7):419. PubMed ID: 20452158
[No Abstract] [Full Text] [Related]
18. FDA notifications. Two tenofovir containing products are approved.
AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16795142
[No Abstract] [Full Text] [Related]
19. Gilead sciences releases Viread.
Giles C
Surviv News (Atlanta Ga); 2002 Jan; ():15. PubMed ID: 11870987
[No Abstract] [Full Text] [Related]
20. Generic Truvada approved.
AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
[No Abstract] [Full Text] [Related]
[Next] [New Search]
